Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis

PURPOSE: We sought to investigate the effectiveness and safety of dabrafenib in children with BRAF(V600E)-mutated Langerhans cell histiocytosis (LCH). MATERIALS AND METHODS: A retrospective analysis was performed on 20 children with BRAF(V600E)-mutated LCH who were treated with dabrafenib. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Wang, Dong, Cui, Lei, Ma, Hong-Hao, Zhang, Li, Lian, Hong-Yun, Zhang, Qing, Zhao, Xiao-Xi, Zhang, Li-Ping, Zhao, Yun-Ze, Li, Na, Wang, Tian-You, Li, Zhi-Gang, Zhang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812025/
https://www.ncbi.nlm.nih.gov/pubmed/32972045
http://dx.doi.org/10.4143/crt.2020.769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812025/
https://www.ncbi.nlm.nih.gov/pubmed/32972045
http://dx.doi.org/10.4143/crt.2020.769

Ejemplares similares